Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents.
Svanborg P, Thernlund G, Gustafsson PA, Hägglöf B, Schacht A, Kadesjö B. Svanborg P, et al. Among authors: schacht a. Eur Child Adolesc Psychiatry. 2009 Dec;18(12):725-35. doi: 10.1007/s00787-009-0031-x. Epub 2009 May 23. Eur Child Adolesc Psychiatry. 2009. PMID: 19466476 Free PMC article. Clinical Trial.
Atomoxetine's effect on societal costs in Sweden.
Myrén KJ, Thernlund G, Nylén A, Schacht A, Svanborg P. Myrén KJ, et al. Among authors: schacht a. J Atten Disord. 2010 May;13(6):618-28. doi: 10.1177/1087054709332163. Epub 2009 Apr 13. J Atten Disord. 2010. PMID: 19365087 Clinical Trial.
Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study.
Wehmeier PM, Dittmann RW, Schacht A, Minarzyk A, Lehmann M, Sevecke K, Lehmkuhl G. Wehmeier PM, et al. Among authors: schacht a. J Child Adolesc Psychopharmacol. 2007 Dec;17(6):813-30. doi: 10.1089/cap.2007.0025. J Child Adolesc Psychopharmacol. 2007. PMID: 18315453 Clinical Trial.
A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
Harfterkamp M, van de Loo-Neus G, Minderaa RB, van der Gaag RJ, Escobar R, Schacht A, Pamulapati S, Buitelaar JK, Hoekstra PJ. Harfterkamp M, et al. Among authors: schacht a. J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733-41. doi: 10.1016/j.jaac.2012.04.011. Epub 2012 May 25. J Am Acad Child Adolesc Psychiatry. 2012. PMID: 22721596 Clinical Trial.
Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM. Dittmann RW, et al. Among authors: schacht a. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):97-110. doi: 10.1089/cap.2009.0111. Epub 2011 Apr 13. J Child Adolesc Psychopharmacol. 2011. PMID: 21488751 Clinical Trial.
Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS).
Wehmeier PM, Schacht A, Lehmann M, Dittmann RW, Silva SG, March JS. Wehmeier PM, et al. Among authors: schacht a. Child Adolesc Psychiatry Ment Health. 2008 May 28;2(1):11. doi: 10.1186/1753-2000-2-11. Child Adolesc Psychiatry Ment Health. 2008. PMID: 18507848 Free PMC article.
Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials.
Wehmeier PM, Schacht A, Escobar R, Savill N, Harpin V. Wehmeier PM, et al. Among authors: schacht a. Child Adolesc Psychiatry Ment Health. 2010 Dec 6;4:30. doi: 10.1186/1753-2000-4-30. Child Adolesc Psychiatry Ment Health. 2010. PMID: 21134277 Free PMC article.
Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder.
Wehmeier PM, Schacht A, Dittmann RW, Helsberg K, Schneider-Fresenius C, Lehmann M, Bullinger M, Ravens-Sieberer U. Wehmeier PM, et al. Among authors: schacht a. Qual Life Res. 2011 Jun;20(5):691-702. doi: 10.1007/s11136-010-9803-5. Epub 2010 Dec 7. Qual Life Res. 2011. PMID: 21136299 Clinical Trial.
235 results